Target intelligence / Profile preview

Glutamate [N-methyl-D-aspartate] receptor subunit epsilon-2 (GluN2B)

Target
GluN2B
Molecular classification
Ion channel, Ligand-gated ion channel, Receptor, Glutamate receptor, N-methyl-D-aspartate receptor (NMDA receptor) subunit
01

Overview

The GluN2B subunit-containing NMDA receptor is a subtype of glutamate receptor—a ligand-gated ion channel mediating excitatory neurotransmission in the central nervous system. NMDA receptors are heterotetrameric complexes typically consisting of two GluN1 and two GluN2 subunits (GluN2A-D), with GluN2B conferring distinct channel and pharmacological properties. GluN2B-containing NMDA receptors are highly expressed in the developing brain and certain adult regions, including forebrain and cortex. They play key roles in synaptic plasticity, learning, memory, and pain processing, and their dysregulation is implicated in multiple neuropsychiatric and neurodegenerative conditions. Selective inhibition of GluN2B-containing NMDA receptors is a validated therapeutic strategy for CNS disorders, though side effects remain a challenge.

Other names
NR2B subunitGluN2BGRIN2BGluRε2GluR2BNMDA receptor subunit epsilon-2
02

Mechanism of action

Allosteric inhibition (binding to NR2B-specific sites to block NMDA receptor function) - Channel block (preventing Ca²⁺ influx through the receptor) - Modulation of synaptic localization and receptor trafficking - Reduction of glutamatergic neurotransmission - Interference with downstream excitotoxic signaling

03

Biological functions

Signal transductionSynaptic plasticityLearning and memoryPain perceptionNeuronal developmentRegulation of dendritic spine densityCellular trafficking and compartmentalization at synapse
04

Disease associations

Neurodegenerative disease (Alzheimer's, Huntington's, Parkinson's)Chronic painDepressionSchizophreniaStroke/IschemiaEpilepsyOther CNS disorders
05

Safety considerations

Impaired cognitive function (learning and memory deficits with excessive inhibition)Psychotomimetic side effectsPotential for neurotoxicity with long-term blockadeInterference with normal synaptic plasticityNon-selective effects of NMDAR antagonists
06

Interacting drugs

Ifenprodil

6 more in the full profile.

07

Biomarkers

NR2B expression levels (brain tissue, CSF)Phosphorylation status of NR2B (e.g., Tyr1472)GRIN2B mRNA/protein quantificationPSD-95 complex association

Beyond the preview

Go deeper on Glutamate [N-methyl-D-aspartate] receptor subunit epsilon-2 (GluN2B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate [N-methyl-D-aspartate] receptor subunit epsilon-2 (GluN2B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call